MedMira Receives US Trademark for its REVEALCOVID-19

MedMira
Sep 20, 2022
1 min read

MedMira is delighted to announce the receipt of the United States of America Trademark for its REVEALCOVID-19 brand. The Company has been successful in its argument to receive the registered trademark for its COVID-19 Antibody related product lines.

Recent Posts

See All

MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal® G4 HIV-1/2 rapid test for VA, Department of Defence

MedMira Announces Partnership with MediGroup Physician Services in the United States

MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada.

Halifax, Nova Scotia, 25th of February, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today its exclusive distribution agreement...

Comments